The effect of apolipoprotein E gene polymorphism and Lp(a) levels on coronary artery disease with atrial fibrillation. Issue 7 (July 2022)

• Record Type: Journal Article
• Authors: Li, Yong; Chen, Lei; Shao, Yameng; Zhang, Min; Zhi, Li; Lu, Yuan
• Is Part Of: Journal of international medical research. Volume 50:Issue 7(2022)
• Publication Date: 2022-07
• Subjects: Apolipoprotein E -- Lp(a) levels -- coronary artery disease -- atrial fibrillation -- lipoprotein (a) -- APOE alleles; Medicine -- Periodicals; Pharmacology -- Periodicals; 610.5
• DOI: 10.1177/03000605221109387
• Languages: English
• ISSNs: 0300-0605

Abstract

Objective: To explore the influence of apolipoprotein E ( APOE ) genotypes and blood lipid metabolism on coronary artery disease (CAD) with atrial fibrillation (AF). Methods: Patients with suspected CAD were consecutively enrolled and divided into groups with or without CAD and/or AF. Blood lipid levels and APOE genotypes were determined and analysed for associations with CAD and AF. Results: A total of 2048 patients were included (400 patients without CAD or AF [controls], 126 patients without CAD but with AF, 1294 patients with CAD without AF, and 228 patients with CAD and AF). Age and lipoprotein (a) (Lp[a]) levels were significantly higher in patients with CAD and AF versus those with CAD without AF. Among patients with CAD, the E3/E3 genotype and ε3 allele frequencies were significantly lower in patients with AF than in those without AF, and the E4/E4 genotype and ε4 allele frequencies were significantly increased. Multivariate logistic regression revealed that increased Lp(a) levels and age were independent risk factors for AF in patients with CAD. Conclusion: Among patients with CAD, those with AF had increased age, ε4 frequencies and Lp(a) levels. Age and Lp(a) levels may be independent risk factors for AF in patients with CAD.